why choose us

Clinical Trials Search

Showing 13,690 of 132,366 result(s)
INF108F in Infants With Food Protein Induced Proctocolitis

Status: Completed

Condition: Infant Development

Interventions: Oral suspension

Date: 2023-03-17

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

Status: Completed

Condition: Malignant Solid Tumor

Interventions: ZL-1218 dose escalation

Date: 2023-03-17

Motivational Refinements for Facilitating Reinforcement Schedule Thinning

Status: Completed

Condition: Decreasing Destructive Behavior

Interventions: During traditional schedule thinning during functional communication training with discriminative stimuli (e.g., multiple schedules, chained schedules

Date: 2023-03-17

Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound

Status: NOT_YET_RECRUITING

Condition: Healthy

Interventions: This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effec

Date: 2023-03-17

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Status: Completed

Condition: Advanced or Metastatic Solid Tumors

Interventions: Oral medication taken daily

Date: 2023-03-17

Effect of Radial Shockwave on Calf Muscle Spasticity in Patients With Cerebral Palsy

Status: Completed

Condition: Cerebral Palsy

Interventions: One session per week of rSWT will be applied using the BMI-1120 SHOCK MED device (BIO-MED-INC- ITALY).
The following parameters will be used: Sho

Date: 2023-03-17

Blood Donation Could Improve Insulin Sensitivity

Status: Completed

Condition: Ferritin

Interventions: Effects of a standard whole blood donation on iron stores and insulin sensitivity.

Date: 2023-03-17

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Status: Completed

Condition: SCN2A Encephalopathy

Interventions: Once daily oral or G-tube treatment.

Date: 2023-03-17

A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors

Status: Completed

Condition: Advanced Solid Tumor

Interventions: Part 1: IV infusion of LB101 Q2W (28-day cycle) and Part 2: IV infusion of LB101

Date: 2023-03-17